In Peer Reviewed Journals
Akl EA, Briel M, You JJ, Sun X, Johnston
BC, Busse JW, Mulla S, Lamontagne F, Bassler D, Vera C, Alshurafa M, Katsios
CM, Zhou Q, Cukierman-Yaffe T, Gangji A, Mills EJ, Walter SD, Cook DJ, Schünemann
HJ, Altman DG, Guyatt GH. Potential
impact on estimated treatment effects of information lost to follow-up in
randomised controlled trials (LOST-IT): systematic review. BMJ 2012; 344: e2809.
Altman DG, McShane LM, Sauerbrei W, Taube SE.
Reporting recommendations for tumor marker prognostic studies (REMARK):
explanation and elaboration. BMC Med
2012; 10: 51.
Altman DG, McShane LM, Sauerbrei W, Taube SE.
Reporting recommendations for tumor marker prognostic studies (REMARK):
explanation and elaboration. PLoS Med
2012; 9: e1001216.
Altman DG, Moher D,
Schulz KF. Improving the reporting of randomised trials: the CONSORT Statement
and beyond. Stat Med 2012; 31: 2985-2997.
Blanchard-Rohner
G, Watt H, Kelly DF, Yu LM, Snape
MD, Pollard AJ. Baseline polysaccharide-specific antibodies may not
consistently inhibit booster antibody responses in infants to a serogroup C
meningococcal protein-polysaccharide conjugate vaccine. Vaccine 2012; 30: 4153-4159.
Bland JM,
Altman DG. Agreed statistics:
measurement method comparison. Anesthesiology
2012; 116: 182-185.
Boone D,
Halligan S, Mallett S, Taylor SA, Altman DG. Systematic review: Bias in
imaging studies – the effect of manipulating clinical context, recall bias and
reporting intensity. Eur Radiol 2012;
22: 495-505.
Bouwmeester
W, Zuithoff NPA, Mallett S, Geerlings MI, Vergouwe Y, Steyerberg EW, Altman DG, Moons KGM. Reporting and
methods in clinical prediction research: a systematic review. PLoS Med 2012; 9: e1001221.
Campbell
MK, Piaggio G, Elbourne DR, Altman DG.
CONSORT 2010 Statement: extension to cluster randomised trials. BMJ 2012; 345: e5661.
Caocci G, Efficace F, Ciotti F, Roncarlo MG, Vacca A,
Piras E, Littera R, Markous RSD, Collins
GS, Ciceri F, Mandelli F, Marktel S, La Nasa G. Health related
quality of life in Middle Eastern children with beta-thalassemia. BMC Blood Disorders 2012; 12: 6.
Clutterbuck
EA, Lazarus R, Yu LM, Bowman J,
Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, Pollard AJ.
Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects
on antigen-specific B CELLS. J Infect Dis 2012; 205: 1408-16.
Collins GS. Validating predictive
models for colorectal cancer. Colorectal
Cancer 2012; 1: 371-374.
Collins GS, Altman DG. Identifying patients with undetected colorectal cancer: an independent validation of QCancer® (colorectal). Br J Cancer 2012; 107: 260-265.
Collins GS, Altman DG. Identifying women with undetected ovarian cancer:
independent validation of QCancer® (ovarian) prediction
model. Eur J Cancer Care 2012 Nov 2 [Epub ahead of print].
Collins GS, Altman DG. Predicting the 10 year risk of cardiovascular disease in
the United Kingdom: independent and external validation of an updated version
of QRISK2. BMJ 2012; 344: e4181.
Collins GS, Altman DG. Predicting the adverse risk of statin treatment: an
independent and external validation of QStatin risk scores in the UK. Heart 2012; 98: 1091-1097.
Collins GS, Altman DG. Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney® scores using a primary care database. Br J Gen Pract 2012; 62: 243-250.
Collins GS, Le Manach Y. Comparing treatment effects between
propensity scores and randomized controlled trials: improving conduct and
reporting. Eur Heart J 2012; 33:
1867-1869.
Collins GS, Michaëlsson K. Fracture
risk assessment: state of the art, methodologically unsound, or poorly
reported? Curr Osteoporosis Rep 2012;
10: 199-207.
Collins GS, Moons KGM. Comparing risk prediction models. BMJ 2012; 344: e3186.
Crowther
CA, Aghajafari F, Askie LM, Asztalos EV, Brocklehurst P, Bubner TK, Doyle LW,
Dutta S, Garite TJ, Guinn DA, Hallman M, Hannah ME, Hardy P, Maurel K, Mazumder
P, McEvoy C, Middleton PF, Murphy KE, Peltoniemi OM, Peters D, Sullivan L, Thom
EA, Voysey M, Wapner RJ, Yelland L,
Zhang S. Repeat prenatal corticosteroid prior to preterm birth: a systematic
review and individual participant data meta-analysis for the PRECISE study
group (prenatal repeat corticosteroid international IPD study group: assessing
the effects using the best level of evidence) – study protocol. Syst Rev 2012; 1: 12.
Dekkers
OM, Egger M, Altman DG,
Vandenbroucke JP. Distinguishing case series from cohort studies. Ann Intern Med 2012; 156: 37-40.
Dinnes J,
Hewison J, Altman DG, Deeks JJ. The
basis for monitoring strategies in clinical guidelines: a case study of
prostate-specific antigen for monitoring in prostate cancer. CMAJ 2012; 184: 169-77.
Eddleston
M, Street JM, Self I, Thompson A, King T, Williams
N, Naredo G, Dissanayake K, Yu LM,
Worek F, John H, Smith S, Thiermann H, Harris JB, Eddie Clutton R. A role for
solvents in the toxicity of agricultural organophosphorus pesticides. Toxicology 2012; 294: 94-103.
Ellenberg
S, Fernandes RM, Saloojee H, Bassler D, Askie L, Vandermeer B, Offringa M, Van
der Tweel I, Altman DG, van der Lee
JH for the StaR Child Health Group. Standard 3: Data Monitoring Committees. Pediatrics 2012; 129: S132-S137.
Gossger
N, Snape MD, Yu LM, Finn A, Bona G,
Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, Kieninger D, Prymula
R, Dull P, Ypma E, Toneatto D, Kimura A, Pollard AJ; European MenB Vaccine
Study Group. Immunogenicity and tolerability of recombinant serogroup B
meningococcal vaccine administered with or without routine infant vaccinations
according to different immunization schedules: a randomized controlled trial. JAMA 2012; 307: 573-582.
Greaves P, Clear A, Coutinho R, Wilson A, Matthews J,
Owen A, Shanyinde M, Lister TA,
Calaminici M, Gribben JG. Expression of FOXP3, CD68, and CD20 at diagnosis in
the microenvironment of classical Hodgkin lymphoma is predictive of outcome. J
Clin Oncol 2012 Oct 8 [Epub ahead
of print].
Gray R,
Sullivan M, Altman DG, Gordon-Weeks
AN. Adherence of trials of operative intervention to the CONSORT statement extension
for non-pharmacological treatments: a comparative before and after study. Ann R Coll Surg 2012; 94: 388-394.
Groenwold
RHH, White IR, Donders ART, Carpenter JR, Altman
DG, Moons KGM. Missing covariate data in clinical research: when and when
not to use the indicator method. CMAJ
2012; 184: 1265-1269.
Hanney M,
Prasher V, Williams N, Jones EL,
Aarsland D, Corbett A, Lawrence D, Yu LM,
Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C; on behalf of the MEADOWS
trial researchers. Memantine for dementia in adults older than 40 years with
Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled
trial. Lancet 2012; 379: 528-536.
Hirst A, Altman DG. Are peer reviewers
encouraged to use reporting guidelines? A survey of 116 health research
journals. PLoS One 2012; 7: e35621.
Hopewell S, Simera I. Reporting
guidelines: increasing standards in clinical research reporting. Eur J Hosp
Pharm 2012; 19: 502-506.
Hopewell S, Ravaud P,
Baron G, Boutron I. Effect of editors’ implementation of CONSORT guidelines on
the reporting of abstracts in high impact medical journals: interrupted time
series analysis. BMJ 2012; 344:
e4178.
Howard R,
McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T,
Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I,
Macharouthu A, O’Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R,
Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P,
Phillips P. Donepezil and memantine for moderate-to-severe Alzheimer’s disease.
N Engl J Med 2012; 366: 893-903.
Huijbers
A, Tollenaar RA, V Pelt GW, Zeestraten EC, Dutton
S, McConkey CC, Domingo E, Smit VT, Midgley R, Warren BF, Johnstone EC,
Kerr DJ, Mesker WE. The proportion of tumor-stroma as a strong prognosticator
for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol 2012 Aug 2. [Epub ahead of
print]
Independent
UK Panel of Breast Cancer Screening [includes Altman DG]. The benefits and harms of breast cancer screening: an
independent review. Lancet 2012; 380:
1778-1786.
Independent
UK Panel of Breast Cancer Screening [includes Altman DG]. The benefits and
harms of breast cancer screening: an independent review. A report jointly
commissioned by Cancer Research UK and the Department of Health (England), 2012.
Jani A,
Jenner L, Ma F, Dutton S, Stevens R,
Sharma RA. Referral proformas improve compliance to national colorectal
two-week wait targets: Does this impact on cancer detection rates? Colorectal Dis 2012; 14: 1351-1356.
Karamitsos
TD, Arnold JR, Pegg TJ, Francis JM, Birks
J, Jerosch-Herold M, Neubauer S, Selvanayagam JB. Patients with syndrome X
have normal transmural myocardial perfusion and oxygenation: a 3 Tesla
cardiovascular magnetic resonance imaging study. Circ Cardiovasc Imaging 2012; 5: 194-200.
Kennedy
RH, Francis A, Dutton S, Love S, Pearson S, Blazeby JM, Quirke
P, Franks PJ, Kerr DJ. EnROL: A multicentre randomised trial of conventional
versus laparoscopic surgery for colorectal cancer within an enhanced recovery
programme. BMC Cancer 2012; 12: 181.
Khatami
A, Snape MD, Davis E, Layton H, John T, Yu
LM, Dull PM, Gill CJ, Odrjlin T, Dobson S, Halperin SA, Langley JM, McNeil
SA, Pollard AJ. Persistence of the immune response at 5 years of age following
infant immunisation with investigational quadrivalent MenACWY conjugate vaccine
formulations. Vaccine 2012; 30:
2831-2838.
Khatami
A, Snape MD, Wysocki J, John TM, Westcar S, Mesaros N, Peddiraju K, Boutriau D,
Yu LM, Pollard AJ. Persistence of
Antibody Response Following a Booster Dose of Hib-MenC-TT Glycoconjugate
Vaccine to Five Years: A Follow-Up Study. Pediatr
Infect Dis J 2012; 31: 1069-1073.
Kilkenny
C, Browne WJ, Cuthill IC, Emerson M, Altman
DG. Improving bioscience research reporting: the ARRIVE guidelines for
reporting animal research. Vet Clin
Pathol 2012; 41: 27-31.
Kilkenny
C, Browne WJ, Cuthill IC, Emerson M, Altman
DG. Improving bioscience research reporting: the ARRIVE guidelines for
reporting animal research. Osteoarthritis
Cartilage 2012; 20: 256-260.
Knight SJ, Yau C, Clifford R,
Timbs AT, Akha
ES, Dréau HM, Burns A, Ciria C, Oscier DG,
Pettitt AR, Dutton S, Holmes CC, Taylor J,
Cazier JB, Schuh
A. Quantification of subclonal
distributions of recurrent genomic aberrations in paired pre-treatment and
relapse samples from patients with B-cell chronic lymphocytic leukemia. Leukemia
2012; 26:
1564-1575.
Lambe T,
Spencer AJ, Mullarkey CE, Antrobus RD, Yu
LM, de Whalley P, Thompson BA, Jones C, Chalk J, Kerridge S, Hill AV, Snape
MD, Pollard AJ, Gilbert SC. T-Cell responses in children to internal influenza
antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and
response to revaccination with seasonal trivalent inactivated influenza vaccine.
Pediatr Infect Dis J 2012; 31:
e86-91.
Le Manach Y, Collins
GS, Ibanez C, Goarin JP, Coriat P, Gaudric J, Riou B, Landais P. Impact of perioperative
bleeding on the protective effect of β-blockers during infrarenal aortic
reconstruction. Anesthesiology 2012;
117: 1203-1211.
Lee CK, Marschner I, Simes J, Voysey M, Egleston BL, Hudes G, de
Souza PL. Increase in cholesterol predicts survival advantage in renal cell
carcinoma patients treated with temsirolimus. Clin Cancer Res 2012; 18: 3188-3196.
Lee M, Tajar A,
Ravindrarajah R, Pye SR, O'Connor DB, Corona G, O'Connell M, Gielen E, Boonen
S, Vanderschueren D, Pendleton N, Finn JD, Bartfai G, Casanueva FF, Forti G,
Giwercman A, Han TS., Huhtaniemi IT, Kula K, Lean ME, Punab M, Wu FC, O'Neill
TW. Frailty and sexual health in older European men. J Gerontol A Biol Sci
Med Sci 2012 Oct 25 [Epub ahead of print].
Leroy S, Romanello C, Smolkin V, Galetto-Lacour
A, Korczowski B, Tuerlinckx D, Rodrigo C, Gajdos V, Moulin F, Pecile P, Halevy
R, Gervaix A, Duhl B, Vander Borght T, Prat C, Foix-L’hélias L, Altman DG, Gendrel D, Bréart G,
Chalumeau M. Prediction of moderate and high grade vesicoureteral reflux after
a first febrile urinary tract infection in children: construction and internal
validation of a clinical decision rule. J
Urol 2012; 187: 265-271.
Liu J, Sills ES, Yang Z, Salem SA, Rahil T, Collins GS, Liu X, Salem RD. Array
comparative genomic hybridization screening in IVF significantly reduces number
of embyros available for cryopreservation. Clin
Exp Reprod Med 2012; 39: 52-57.
Mallett S,
Halligan S, Thompson M, Collins GS,
Altman DG. Interpreting
diagnostic accuracy studies for patient care. BMJ 2012; 345: e3999.
Metz JA,
Hanieh S, Pradhan R, Joshi A, Shakya D, Shrestha L, Shrestha A, Upadhyay B,
Kelly SC, John TM, Maharjan BD, Yu LM,
Omar O, Borrow R, Findlow J, Kelly
DF, Thorson SM, Adhikari N, Murdoch DR, Pollard AJ. Evaluation of Haemophilus
influenzae type b vaccine for routine immunization in Nepali infants. Pediatr Infect Dis J 2012; 31: e66-72.
Moher D, Hopewell S, Schulz KF, Montori V,
Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated
guidelines for reporting parallel group randomised trials. Int J Surg 2012; 10: 28-55.
Moher D,
Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger
M, Altman DG. CONSORT 2010 Spiegazione ed elaborazione: linee guida aggiornate
per il reporting di trial randomizzati a gruppi paralleli. (In Italian) Evidence 2012; 4: e1000025.
Montoto S, Shaw K, Okosun J, Gandhi S, Fields P,
Wilson A, Shanyinde M, Cwynarski K,
Marcus R, De Vos J, Young AM, Tenant-Flowers M, Orkin C, Johnson M, Chilton D,
Gribben JG, Bower M. HIV status does not influence outcome in patients with
classical Hodgkin lymphoma treated with chemotherapy using doxorubicin,
bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral
therapy era. J Clin Oncol 2012; 30: 4111-4116.
Moons
KGM, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE. Risk prediction models: I. Development,
internal validation, and assessing the incremental value of a new (bio)marker. Heart 2012; 98: 683-690.
Moons
KGM, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, Woodward M. Risk prediction models: II. External
validation, model updating and impact assessment. Heart 2012; 98: 691-698.
National Institute for Health and Clinical Excellence
[includes Collins GS]. Osteoporosis:
assessing the risk of fragility fracture. (Clinical guideline 146.) 2012. www.nice.org.uk/CG146.
Nyangoma
SO, Collins SI, Altman DG, Johnson
P, Billingham LJ. Sample size calculations for designing clinical proteomic
profiling studies using mass spectrometry. Stat
Appl Genet Mol Biol 2012; 11: 2.
Perrett
KP, Jin C, Clutterbuck E, John TM, Winter AP, Kibwana E, Yu LM, Curtis N, Pollard AJ. B Cell Memory to a Serogroup C
Meningococcal conjugate vaccine in childhood and response to booster: little
association with serum IgG antibody. J
Immunol 2012; 189: 2673-2681.
Piaggio
G, Elbourne DR, Pocock SJ, Evans SJW, Altman
DG, for the CONSORT Group. Reporting of noninferiority and equivalence
randomized trials: extension of the CONSORT 2010 Statement. JAMA 2012; 308: 2594-2604.
Rabar S,
Lau R, O’Flynn N, Li L, Barry P; Guideline Development Group [includes Collins GS]. Risk assessment of
fragility fractures: summary of NICE guidance. BMJ 2012; 345: e3698.
Rowland R, Pathan AA, Satti I, Poulton ID, Matsumiya
MM, Whittaker M, Minassian AM, O’Hara GA, Hamill M, Scott JT, Harris SA, Poyntz
HC, Bateman C, Meyer J, Williams N,
Gilbert SC, Lawrie AM, Hill AV, McShane H. Safety and immunogenicity of an
FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate
vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial. Hum Vaccin Immunother 2012; 9 [Epub ahead of print].
Rutter MK, Sattar N, Tajar A, O’Neill TW, Lee DM, Bartfai G, Boonen S, Casanueva FF,
Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi I, Kula K, Lean M, Pendleton
N, Punab M, Silman AJ, Vanderschueren D, Lowe GD, O'Rahilly S, Morris R, Wu FC,
Wannamethee SG. Epidemiological evidence against a role for C-reactive protein
causing leptin resistance. Eur J Endocrinol 2012 Oct 9 [Epub ahead of print].
Sarris I,
Ioannou C, Chamberlain P, Ohuma E,
Roseman F, Hoch L, Altman DG,
Papageorghiou AT on behalf of the International Fetal and Newborn Growth
Consortium for the 21st Century (INTERGROWTH-21st). Intra- and interobserver
variability in fetal ultrasound measurements. Ultrasound Obstet Gynecol 2012; 39: 266-273.
Savović
J, Jones HE, Altman DG, Harris RJ,
Jüni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JPA,
Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JAC.
Influence of reported study design characteristics on intervention effect estimates
from randomized, controlled trials: combined analysis of meta-epidemiologic
studies. Ann Intern Med 2012; 157:
429-438.
Savović J, Jones
HE, Altman DG, Harris RJ, Jüni P,
Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JPA, Schulz KF,
Beynon R, Welton N, Wood L, Moher D, Deeks JJ, Sterne JAC. Influence of
reported study design characteristics on intervention effect estimates from
randomised controlled trials: combined analysis of meta-epidemiological
studies. Health Technol Assess 2012; 16(35):
1-82.
Schriger
DL, Savage DF, Altman DG. The
presentation of continuous outcomes in randomised trials: an observational
study. BMJ 2012; 345: e8486.
Schulz
KF, Altman DG, Moher D, the CONSORT
Group. CONSORT Statement 2010: linee guida aggiornate per il reporting di trial
randomizzati a gruppi paralleli. (In Italian) Evidence 2012; 4: e1000024.
Shamseer
L, Stevens A, Skidmore B, Turner L, Altman
DG, Hirst A, Hoey J, Palepu A, Simera I, Schulz KF, Moher D. Does
journal endorsement of reporting guidelines inuence the completeness of
reporting of health research? A systematic review protocol. Syst Rev 2012; 1: 24.
Sills ES, Collins
GS, Salem SA, Jones CA, Peck AC, Salem RD. Balancing selected medication
costs with total number of daily injections: a preference analysis of
GnRH-agonist and antagonist protocols by IVF patients. Reprod Biol
Endocrinol 2012; 10: 67.
Sinha IP,
Altman DG, Beresford MW, Boers M,
Clarke M, Craig J, Della Casa Alberighi O, Fernandes RM, Hartling L, Johnston
BC, Lux A, Plint A, Tugwell P, Turner M, van der Lee JH, Offringa M, Williamson
PR, Smyth RL for the StaR Child Health Group. Standard 5: Selection,
measurement, and reporting of outcomes. Pediatrics
2012; 129: S146-S152.
Stewart
GB, Altman DG, Askie LM, Duley L,
Simmonds MC, Stewart LA. Statistical analysis of individual participant
meta-analyses: a comparison of methods and recommendations for practice. PLoS One 2012; 7: e46042.
Sullivan
PB, Alder N, Shrestha B, Turton L,
Lambert B. Effectiveness of using a behavioural intervention to improve dietary
fibre intakes in children with constipation. J Hum Nutr Diet 2012; 25: 33-42.
Sun X,
Briel M, Busse JW, You JJ, Akl EA, Mejza F, Bala MM, Bassler D, Mertz D,
Diaz-Granados N, Vandvik PO, Malaga G, Srinathan SK, Dahm P, Johnston BC,
Alonso-Coello P, Hassouneh B, Walter SD, Heels-Ansdell D, Bhatnagar N, Altman DG, Guyatt GH. Credibility of
claims of subgroup effects in randomised controlled trials: systematic review. BMJ 2012; 344: e1553.
Tajar A, Lee DM,
Pye SR, O'Connell MD, Ravindrarajah R, Gielen E, Boonen S, Vanderschueren D,
Pendleton N, Finn JD, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS,
Huhtaniemi IT, Kula K, Lean ME, Punab M, Wu FC, O'Neill TW. The association of
frailty with serum 25-hydroxyvitamin D and parathyroid hormone levels in older
European men. Age Ageing 2012 Oct
30 [Epub ahead of print].
The
Esophageal Adenocarcinoma Genetics Consortium [includes Love S]. Common variants at the MHC locus and at chromosome 16q24.1
predispose to Barrett’s esophagus. Nat
Genet 2012; 44: 1131-1136.
Travis
SPL, Schnell D, Krzeski P, Abreu MT, Altman
DG, Colombel JF, Feagan BG, Hanauer SB, Lémann M, Lichtenstein GR, Marteau
PR, Reinisch W, Sands BE, Yacyshyn BR, Bernhardt CA, Mary JY, Sandborn WJ.
Developing an instrument to assess the endoscopic severity of ulcerative
colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012; 61: 535-542.
Turner L,
Shamseer L, Altman DG, Weeks L,
Peters J, Kober T, Dias S, Schulz KF, Plint AC, Moher D. Consolidated standards
of reporting trials (CONSORT) and the completeness of reporting of randomised
controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012; 11: MR000030.
Van der
Tweel I, Askie L, Vandermeer B, Ellenberg S, Fernandes RM, Saloojee H, Bassler
D, Altman DG, Offringa M, van der
Lee JH for the StaR Child Health Group. Standard 4: Determining adequate sample
sizes. Pediatrics 2012; 129:
S138-S145.
Williamson
PR, Altman DG, Blazeby JM, Clarke M,
Devane D, Gargon E, Tugwell P. Developing core outcome sets for clinical
trials: issues to consider. Trials
2012; 13: 132.
Wright S,
Duncombe P, Altman DG. Assessment of
blinding to treatment allocation in studies of a cannabis-based medicine
(Sativex®) in people with multiple sclerosis: a new approach. Trials 2012; 13: 189.
Yaffe J,
Montgomery P, Hopewell S, Shepard
LD. Empty reviews: a description and consideration of Cochrane systematic
reviews with no included studies. PLoS
One 2012; 7: e36626.
Yang H, Wu H, Hancock G, Clutton G, Sande N, Xu X, Yan
H, Huang X, Angus B, Kuldanek K, Fidler S, Denny TN, Birks J, McMichael A, Dorrell L. The
antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ cell
decline in HIV-1 infection. J Infect Dis
2012; 206: 552-561.
Yang Z, Liu Y, Collins GS, Salem SA, Liu X, Lyle SS, Peck AC, Sills ES, Salem RD. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet 2012; 5: 24.
